Skip to content

Nanoligent vs RS Research

Nanoligent logo

Nanoligent

Our mision is to improve the life of patients by designing new drugs that selectively target affected cells by disease

15 employees · est. 2017 · Spain

VS
RS Research logo

RS Research

Clinically-validated biotech company for targeted therapies, disrupting the efficacy-toxicity trade-off

30 employees · est. 2015 · Istanbul, Turkey

RS Research is the older company (2017 vs 2015).

Side-by-Side Comparison

Nanoligent RS Research
Founded
2017 2015 older
Headquarters
Spain Istanbul, Turkey
Employees
15 30
Industry
Biotechnology, Pharmaceutical Biotechnology, Pharmaceutical
Funding Stage
Seed Series A
Total Funding
$2.80M $14.00M
Funding Rounds
2 4
Services
Not tracked yet Development of targeted oncology therapies, Sagitta® drug delivery platform, Clinical trials for cancer treatment
Target Customers
Not tracked yet Oncologists, Pharmaceutical companies, Research institutions, Healthcare providers
Taxonomy
BiotechDrug DesignNanobiotechnologyCancer TreatmentMetastasisProtein Engineering +9 Clinical-stage BiotechnologySmart NanomedicinesTargeted ChemotherapyDrug Delivery PlatformSagitta®Cancer Therapy +9
Website
nanoligent.com rsresearch.net
Nanoligent logo

About Nanoligent

Nanoligent is a Spanish biotechnology and pharmaceutical startup founded in 2017, with a mission to improve the lives of patients by developing new drugs that selectively target cells affected by disease. Their innovative approach utilizes state-of-the-art protein engineering and nanobiotechnology t...

RS Research logo

About RS Research

RS Research is a clinical-stage biotechnology start-up headquartered in Turkey that is at the forefront of developing smart nanomedicines for targeted chemotherapy. Established in 2015, the company leverages its innovative drug delivery platform, Sagitta®, aiming to provide a “Cure With a Smile” thr...

Also comparing in this category

Comparing more than these two?

Get Nanoligent, RS Research and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Nanoligent compare?

A PDF of Nanoligent and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Nanoligent was founded in 2017, based in Spain, with 15 employees. Nanoligent is a Spanish biotechnology and pharmaceutical startup founded in 2017, with a mission to improve the lives of patients by developing new drugs that selectively target cells affected by dise. RS Research was founded in 2015, based in Istanbul, Turkey, with 30 employees. RS Research is a clinical-stage biotechnology start-up headquartered in Turkey that is at the forefront of developing smart nanomedicines for targeted chemotherapy. Established in 2015, the company le.
Nanoligent has raised $2.80M and RS Research $14.00M. Latest stage: Nanoligent Seed, RS Research Series A.
Both work in Biotechnology and Pharmaceutical.

Compare Nanoligent with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Nanoligent on 12 Sep 2024, and RS Research on 4 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout